Immunology conference

5 February 2019

Dubai World Trade Centre

Overview:

Theme: Improving clinical outcomes through employing immune-based diagnostics and therapeutics

This conference will provide delegates with a unique opportunity to engage with immunology field experts to discuss the latest trends and important issues concerning the widespread utilisation of immunological techniques for healthcare advancement. Regional and international pioneers within immunology and relevant fields will present their research and share novel case-based knowledge throughout the exclusive scientific programme.

Key topics:

  • Autoimmune diseases
  • Primary immunodeficiency
  • Transplant immunology

Benefits of attending

  • Review the role of immune-based diagnostics and therapeutics for improved clinical practice and appraise the potential and pitfalls
  • Explore immune mechanisms and discuss the cellular responses to viral pathogens
  • Discuss the challenges and potential for the use of immunotherapy as a cancer therapeutic
  • Discover innovative therapeutic options to treat allergies

09:20

Opening remarks

Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Dr Zain Ali Al Yafei, Senior Clinical Scientist, Sheikh Khalifa Medical City, Abu Dhabi, UAE


Session 1

Autoimmune Diseases

Moderator: Dr Zain Ali Al Yafei, Senior Clinical Scientist, Sheikh Khalifa Medical City, Abu Dhabi, UAE

09:30

Serological biomarkers in Rheumatoid arthritis

Dr Daniele Ielo, Clinical and Scientific Manager, Autoimmunity, Instrumentation, Werfen, Milan, Italy

10:00

ANCA associated vasculitis

Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

10:30 Coffee Break

11:00

Diabetes mellitus type I

Dr Juliane Brock, Product Manager for Molecular Diagnostics, Euroimmun, Lübeck, Germany

11:30

Antiphospholipid antibodies: an update

Dr Daniele Ielo, Clinical and Scientific Manager, Autoimmunity, Instrumentation, Werfen, Milan, Italy

12:00

Calprotectin in diagnosis and management of Inflammatory Bowel Diseases (IBD)

Dr Philipp Arendt, Product Manager for Antigen Diagnostics, Euroimmun, Lübeck, Germany

12:30 Lunch Break


Session 2

Primary Immunodeficiency

Moderator: Dr Ali Hajeer, Division Head, Immunopathology Laboratory, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, KSA

13:30

Role of flow cytometry in the diagnosis of Chronic Granulomatous disease (CGD)

Dr Zain Ali Al Yafei, Senior Clinical Scientist, Sheikh Khalifa Medical City, Abu Dhabi, UAE

14:00

Newborn screening for Severe Combined Immunodeficiency disease (SCID)

Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

14:30

EBV infection in the immunocompromised

Prof Gulfaraz Khan, Professor, Viral Pathology, Chair, Department of Microbiology & Immunology, College of Medicine, UAE University, Al Ain, UAE

15:00 Coffee Break


Session 3

Transplant Immunology

Moderator: Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

15:30

HLA typing to support transplantation: from serology to Next generation sequencing

Dr Ali Hajeer, Division Head, Immunopathology Laboratory, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, KSA

16:00

Role of Anti HLA antibodies in kidney transplant

Dr Moheeb Al-Awwami, Clinical Director, Histocompatibility and Immunogenetics Laboratory, King Faisal Specialist Hospital & Research Centre, Riyadh, KSA

16:30

Interactive Q & A

17:00 End of conference

Chairs:

Gehad Eltayeb ElGhazali, Consultant Physician, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Zain Ali Al Yafei, Senior Clinical Scientist, Clinical Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE


Activity Director:

Dr Fadi W. Abdul –Karim, Professor of Pathology and Vice Chair for Education, Robert Tomsich Pathology and Laboratory Med Institute, Cleveland Clinic, Ohio, USA


Speaker faculty:

Dr Ali Hajeer, Division Head, Immunopathology Laboratory, King Fahad National Guard Hospital, King Abdulaziz Medical City, Riyadh, KSA

Dr Daniele Ielo, Clinical and Scientific Manager, Autoimmunity, Instrumentation, Werfen, Milan, Italy

Dr Gehad Eltayeb ElGhazali, Consultant Physician, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Prof Gulfaraz Khan, Professor, Viral Pathology, Chair, Department of Microbiology & Immunology, College of Medicine, UAE University, Al Ain, UAE

Dr Juliane Brock, Product Manager for Molecular Diagnostics, Euroimmun, Lübeck, Germany

Dr Moheeb Al-Awwami, Clinical Director, Histocompatibility and Immunogenetics Laboratory,
King Faisal Specialist Hospital & Research Centre, Riyadh, KSA

Dr Philipp Arendt, Product Manager for Antigen Diagnostics, Euroimmun, Lübeck, Germany


Accreditation statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for a maximum of 31.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.


Provided by: